ALISHA WELSH: Open Payments
NPI 1184398810 · MARYSVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,278 in 67 payments from 22 companies in 2025. Trend: 2023 $416 · 2024 $684 · 2025 $1,278
Food & beverage: $1,278
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $277 |
| Vanda Pharmaceuticals Inc. | 9 | $176 |
| ABBVIE INC. | 6 | $97 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $83 |
| Novo Nordisk Inc | 4 | $78 |
| Exact Sciences Corporation | 4 | $66 |
| Antares Pharma, Inc. | 3 | $52 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Amgen Inc. | 3 | $47 |
| Lilly USA, LLC | 3 | $47 |
Products named: FANAPT, FARXIGA, XIFAXAN, AIRSUPRA, VRAYLAR, Wegovy, The Cologuard Plus Collection Kit, XYOSTED.
Industry payments across MI — which companies pay providers there.
